News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Brazzell Romulus K
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| Brazzell Romulus K (SEE REMARKS) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 17,916 shares
@ $0 Disposed/sold 308 options to buy
@ $0 Disposed/sold 2,047 options to buy
@ $0 Disposed/sold 942 options to buy
@ $0 Disposed/sold 1,399 options to buy
@ $0 Disposed/sold 2,999 options to buy
@ $0 Disposed/sold 2,399 options to buy
@ $0 Disposed/sold 2,199 options to buy
@ $0 Disposed/sold 4,759 options to buy
@ $0 Disposed/sold 864 options to buy
@ $0 |
|
03/15/2023 |
4
| Brazzell Romulus K (SEE REMARKS) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 576 options to buy
@ $68.5, valued at
$39.5k
|
|
01/06/2023 |
4
| Brazzell Romulus K (SEE REMARKS) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 12,800 shares
@ $0 Sold 73 shares
@ $28.53, valued at
$2.1k
|
|
10/28/2022 |
4
| Brazzell Romulus K (SEE REMARKS) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Sold 261 shares
@ $6.51, valued at
$1.7k
|
|
06/29/2022 |
4
| Brazzell Romulus K (SEE REMARKS) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Sold 3,144 shares
@ $0.37, valued at
$1.2k
|
|
01/05/2022 |
4
| Brazzell Romulus K (SEE REMARKS) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Sold 3,504 shares
@ $1.3, valued at
$4.6k
Granted 238,000 options to buy
@ $1.37, valued at
$326.1k
|
|
10/28/2021 |
4
| Brazzell Romulus K (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Sold 12,757 shares
@ $1.8, valued at
$23k
|
|
06/29/2021 |
4
| Brazzell Romulus K (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Sold 3,034 shares
@ $5.77, valued at
$17.5k
|
|
01/05/2021 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 27,500 shares
@ $0 Granted 110,000 options to buy
@ $6.86, valued at
$754.6k
|
|
10/28/2020 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 81,000 shares
@ $0 |
|
06/29/2020 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 19,000 shares
@ $0 |
|
04/13/2020 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Exercised 1,880 options to buy
@ $0.68, valued at
$1.3k
Exercised 18,247 options to buy
@ $2.3, valued at
$42k
Exercised 47,644 options to buy
@ $3.34, valued at
$159.1k
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2019 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 150,000 options to buy
@ $5.19, valued at
$778.5k
|
|
02/09/2018 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 70,000 options to buy
@ $12.86, valued at
$900.2k
|
|
08/15/2017 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Exercised 36,094 options to buy
@ $0.68, valued at
$24.5k
Exercised 16,168 options to buy
@ $0.68, valued at
$11k
Exercised 44,313 options to buy
@ $2.3, valued at
$101.9k
Exercised 12,150 options to buy
@ $3.34, valued at
$40.6k
|
|
07/21/2017 |
4
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 47,142 options to buy
@ $15, valued at
$707.1k
|
|
07/19/2017 |
3
| Brazzell Romulus K (Chief Medical Officer) has filed a Form 3 on Kala Pharmaceuticals, Inc. |
05/16/2011 |
4
| Brazzell Romulus K (EVP, Medical & Scientific) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC
Txns:
| Disposed/sold 20,000 shares
@ $5, valued at
$100k
Disposed/sold 26,000 options to buy
@ $7.07, valued at
$183.8k
Disposed/sold 26,000 options to buy
@ $4.8, valued at
$124.8k
Disposed/sold 22,000 options to buy
@ $6.5, valued at
$143k
Disposed/sold 22,000 options to buy
@ $6.08, valued at
$133.8k
Disposed/sold 13,250 options to buy
@ $5.1, valued at
$67.6k
Disposed/sold 13,250 options to buy
@ $4.55, valued at
$60.3k
Disposed/sold 13,250 options to buy
@ $3.84, valued at
$50.9k
Disposed/sold 13,250 options to buy
@ $3.79, valued at
$50.2k
Disposed/sold 10,250 options to buy
@ $3.78, valued at
$38.7k
Disposed/sold 10,250 options to buy
@ $4.44, valued at
$45.5k
|
|
02/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/12/2010 |
4
| Brazzell Romulus K (EVP, Medical & Scientific) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC
Txns:
| Granted 26,000 options to buy
@ $7.07, valued at
$183.8k
Granted 2,600 restricted stock units
@ $0 |
|
08/13/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/13/2010 |
4
| Brazzell Romulus K (EVP & Head, Ophthalmology) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC
Txns:
| Granted 22,000 options to buy
@ $6.5, valued at
$143k
Granted 2,200 restricted stock units
@ $0 |
|
03/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/13/2009 |
4
| Brazzell Romulus K (EVP & Head, Ophthalmology) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC
Txns:
| Granted 13,250 options to buy
@ $5.1, valued at
$67.6k
|
|
08/13/2009 |
4
| Brazzell Romulus K (EVP & Head, Ophthalmology) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC |
05/18/2009 |
4
| Brazzell Romulus K (EVP & Head, Ophthalmology) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC |
03/20/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|